Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barry Skikne, M.D., FACP; FCP (SA)
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Florida
Gainesville, Florida, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Kansas University Medical Center
Westwood, Kansas, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Kansas City Va Medical Center University of Kansas Medical Center
Kansas City, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- New York Oncology Hematology P.C.
Albany, New York, United States
- Institute for Translational Oncology Research Irb
Greenville, North Carolina, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Texas Oncology Cancer Care
Austin, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Hoast
San Antonio, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Yakima Valley Memorial Hospital/ North Star Lodge
Yakima, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2007
- Primary completion
- 31 Jul 2013
- Completion
- 5 Apr 2016
- Last update posted
- 8 Nov 2019
- Registered enrollment
- 133
- Registry id
- NCT00528983
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.